Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Jeffrey Smith's Starboard Value buys Huntsman, exits Offerpad in Q3 » 17:31
11/12/21
11/12
17:31
11/12/21
17:31
CYXT

Cyxtera Technologies

$9.56 /

-0.235 (-2.40%)

, BRDS

Bird Global

$7.83 /

+0.825 (+11.78%)

, ENFA

890 5th Avenue Partners

$9.98 /

+0.015 (+0.15%)

, HUN

Huntsman

$33.78 /

+0.08 (+0.24%)

, VPCC

VPC Impact Acquisition Holdings III

$9.98 /

-0.01 (-0.10%)

, IWN

iShares Russell 2000 Value Index

$174.91 /

-0.315 (-0.18%)

, KVSC

Khosla Ventures Acquisition Co III

$9.97 /

-0.02 (-0.20%)

, ROIV

Roivant Sciences

$8.40 /

+0.57 (+7.28%)

, STRC

Sarcos Technology

$8.00 /

+0.265 (+3.43%)

, OPAD

Offerpad Solutions

$7.97 /

+0.305 (+3.98%)

, IWM

iShares Trust Russell 2000 Index Fund

$239.46 /

+0.21 (+0.09%)

, AUS

Austerlitz Acquisition Corporation I

$9.84 /

-0.11 (-1.11%)

, MTAC

MedTech Acquisition

$9.96 /

-0.025 (-0.25%)

, KIND

Nextdoor

$13.10 /

+0.895 (+7.33%)

, MD

Mednax

$28.34 /

+0.18 (+0.64%)

, BOX

Box

$25.93 /

+0.2 (+0.78%)

, CTVA

Corteva

$48.74 /

+1.06 (+2.22%)

, ELAN

Elanco

$33.03 /

+0.29 (+0.89%)

, ACM

Aecom

$70.81 /

+0.15 (+0.21%)

, NLOK

NortonLifeLock

$25.50 /

+0.46 (+1.84%)

, ON

ON Semiconductor

$58.59 /

+0.37 (+0.64%)

, PZZA

Papa John's

$130.09 /

+0.07 (+0.05%)

Jeffrey Smith's…

Jeffrey Smith's Starboard Value disclosed in an SEC filing its holdings as of September 30, 2021. The fund's 23 new buys during the third quarter included, by size of position, Huntsman (HUN), Cyxtera Technologies (CYXT), Bird Global (BRDS), 890 5th Avenue Partners (ENFA), and VPC Impact Acquisition Holdings III (VPCC). Starboard exited 30 holdings during the quarter, including by size of previous position iShares Russell 2000 Value ETF (IWN), Khosla Ventures Acquisition Co. III (KVSC), Roivant Sciences (ROIV), Sarcos Technology & Robotics (STRC), and Offerpad Solutions (OPAD). The fund increased its stake in 12 holdings, including by size of previous position iShares Russell 2000 ETF (IWM), Austerlitz Acquisition Corp. I Class A (AUS), MedTech Acquisition Corp. (MTAC), Nextdoor (KIND), and L&F Acquisition Corp. Class A (LNFA). Starboard reduced its stake in 13 holdings, including by size of previous position Mednax (MD), Box (BOX), Corteva (CTVA), iShares Russell Mid-Cap ETF (IWR), and Elanco Animal Health (ELAN). The fund's top holdings as of September 30, in order of size, were Aecom (ACM), NortonLifeLock (NLOK), Corteva, ON Semiconductor (ON), and Papa John's (PZZA).

ShowHide Related Items >><<
VPCC VPC Impact Acquisition Holdings III
$9.98 /

-0.01 (-0.10%)

STRC Sarcos Technology
$8.00 /

+0.265 (+3.43%)

ROIV Roivant Sciences
$8.40 /

+0.57 (+7.28%)

PZZA Papa John's
$130.09 /

+0.07 (+0.05%)

OPAD Offerpad Solutions
$7.97 /

+0.305 (+3.98%)

ON ON Semiconductor
$58.59 /

+0.37 (+0.64%)

NLOK NortonLifeLock
$25.50 /

+0.46 (+1.84%)

MTAC MedTech Acquisition
$9.96 /

-0.025 (-0.25%)

MD Mednax
$28.34 /

+0.18 (+0.64%)

KVSC Khosla Ventures Acquisition Co III
$9.97 /

-0.02 (-0.20%)

KIND Nextdoor
$13.10 /

+0.895 (+7.33%)

IWN iShares Russell 2000 Value Index
$174.91 /

-0.315 (-0.18%)

HUN Huntsman
$33.78 /

+0.08 (+0.24%)

ENFA 890 5th Avenue Partners
$9.98 /

+0.015 (+0.15%)

ELAN Elanco
$33.03 /

+0.29 (+0.89%)

CYXT Cyxtera Technologies
$9.56 /

-0.235 (-2.40%)

CTVA Corteva
$48.74 /

+1.06 (+2.22%)

BRDS Bird Global
$7.83 /

+0.825 (+11.78%)

BOX Box
$25.93 /

+0.2 (+0.78%)

AUS Austerlitz Acquisition Corporation I
$9.84 /

-0.11 (-1.11%)

ACM Aecom
$70.81 /

+0.15 (+0.21%)

CYXT Cyxtera Technologies
$9.56 /

-0.235 (-2.40%)

BRDS Bird Global
$7.83 /

+0.825 (+11.78%)

ENFA 890 5th Avenue Partners
$9.98 /

+0.015 (+0.15%)

HUN Huntsman
$33.78 /

+0.08 (+0.24%)

11/11/21 Deutsche Bank
Huntsman price target raised to $40 from $38 at Deutsche Bank
11/02/21 Deutsche Bank
Huntsman price target raised to $38 from $34 at Deutsche Bank
11/01/21 Stifel
Huntsman price target raised to $55 from $50 at Stifel
11/01/21 Barclays
Huntsman price target raised to $36 from $32 at Barclays
VPCC VPC Impact Acquisition Holdings III
$9.98 /

-0.01 (-0.10%)

IWN iShares Russell 2000 Value Index
$174.91 /

-0.315 (-0.18%)

KVSC Khosla Ventures Acquisition Co III
$9.97 /

-0.02 (-0.20%)

ROIV Roivant Sciences
$8.40 /

+0.57 (+7.28%)

11/08/21 H.C. Wainwright
Roivant Sciences initiated with a Buy at H.C. Wainwright
10/27/21 Citi
Roivant Sciences initiated with a Buy at Citi
10/26/21 Jefferies
Jefferies starts Roivant Sciences at Buy with $10 price target
10/26/21 Truist
Roivant Sciences initiated with a Buy at Truist
STRC Sarcos Technology
$8.00 /

+0.265 (+3.43%)

11/08/21 Baird
Sarcos Technology initiated with a Neutral at Baird
10/13/21 Jefferies
Sarcos Technology initiated with a Buy at Jefferies
OPAD Offerpad Solutions
$7.97 /

+0.305 (+3.98%)

10/14/21 JMP Securities
Offerpad Solutions initiated with an Outperform at JMP Securities
09/27/21 Jefferies
Offerpad Solutions initiated with a Hold at Jefferies
IWM iShares Trust Russell 2000 Index Fund
$239.46 /

+0.21 (+0.09%)

03/15/21 Morgan Stanley
Morgan Stanley equity strategist downgrades small cap stocks
AUS Austerlitz Acquisition Corporation I
$9.84 /

-0.11 (-1.11%)

MTAC MedTech Acquisition
$9.96 /

-0.025 (-0.25%)

KIND Nextdoor
$13.10 /

+0.895 (+7.33%)

MD Mednax
$28.34 /

+0.18 (+0.64%)

11/01/21 BMO Capital
Mednax price target lowered to $31 from $37 at BMO Capital
10/13/21 Truist
Mednax price target lowered to $31 from $37 at Truist
09/27/21 SVB Leerink
SVB Leerink starts Mednax at Market Perform with $29 price target
09/27/21 SVB Leerink
Mednax initiated with a Market Perform at SVB Leerink
BOX Box
$25.93 /

+0.2 (+0.78%)

10/07/21
Fly Intel: Top five analyst downgrades
10/07/21 Morgan Stanley
Morgan Stanley downgrades Box on resumption after stock outperformance
10/07/21 Morgan Stanley
Box downgraded to Equal Weight from Overweight at Morgan Stanley
09/27/21
Fly Intel: Top five analyst upgrades
CTVA Corteva
$48.74 /

+1.06 (+2.22%)

10/18/21 Loop Capital
Corteva downgraded to Hold from Buy at Loop Capital
10/18/21 Loop Capital
Corteva downgraded to Hold from Buy at Loop Capital
10/12/21 Mizuho
Corteva initiated with a Buy at Mizuho
10/08/21
Fly Intel: Top five analyst initiations
ELAN Elanco
$33.03 /

+0.29 (+0.89%)

10/28/21
Fly Intel: Top five analyst downgrades
10/28/21 Stifel
Elanco downgraded to Hold from Buy at Stifel
08/24/21 JPMorgan
Elanco 10% pullback brings buying opportunity, says JPMorgan
08/23/21 Alliance Global Partners
Kindred downgraded to Neutral from Buy at Alliance Global Partners
ACM Aecom
$70.81 /

+0.15 (+0.21%)

06/25/21 Citi
Citi sees infrastructure framework as 'tailwind' for infrastructure companies
05/12/21 Credit Suisse
Aecom price target raised to $67 from $59 at Credit Suisse
04/21/21 Citi
Aecom price target raised to $80 from $69 at Citi
04/07/21 Argus
Aecom price target raised to $76 from $60 at Argus
NLOK NortonLifeLock
$25.50 /

+0.46 (+1.84%)

08/11/21 HSBC
Avast downgraded to Hold from Buy at HSBC
07/20/21 Goldman Sachs
Avast downgraded to Neutral from Buy at Goldman Sachs
07/15/21 Barclays
NortonLifeLock price target raised to $32 from $31 at Barclays
05/27/21 Argus
NortonLifeLock price target raised to $32 from $27 at Argus
ON ON Semiconductor
$58.59 /

+0.37 (+0.64%)

11/02/21 BMO Capital
ON Semiconductor price target raised to $50 from $45 at BMO Capital
11/02/21 Truist
ON Semiconductor price target raised to $62 from $51 at Truist
11/02/21 Cowen
ON Semiconductor price target raised to $65 from $58 at Cowen
11/02/21 Craig-Hallum
ON Semiconductor price target raised to $64 from $52 at Craig-Hallum
PZZA Papa John's
$130.09 /

+0.07 (+0.05%)

11/12/21 Benchmark
Papa John's initiated with a Buy at Benchmark
11/05/21
Fly Intel: Top five analyst downgrades
11/05/21 BMO Capital
Papa John's price target raised to $145 from $130 at BMO Capital
11/05/21 Credit Suisse
Papa John's price target raised to $154 from $135 at Credit Suisse
STRC Sarcos Technology
$8.00 /

+0.265 (+3.43%)

PZZA Papa John's
$130.09 /

+0.07 (+0.05%)

ON ON Semiconductor
$58.59 /

+0.37 (+0.64%)

NLOK NortonLifeLock
$25.50 /

+0.46 (+1.84%)

MD Mednax
$28.34 /

+0.18 (+0.64%)

HUN Huntsman
$33.78 /

+0.08 (+0.24%)

ELAN Elanco
$33.03 /

+0.29 (+0.89%)

CYXT Cyxtera Technologies
$9.56 /

-0.235 (-2.40%)

CTVA Corteva
$48.74 /

+1.06 (+2.22%)

BOX Box
$25.93 /

+0.2 (+0.78%)

ACM Aecom
$70.81 /

+0.15 (+0.21%)

  • 20
    Aug
  • 01
    Dec
NLOK NortonLifeLock
$25.50 /

+0.46 (+1.84%)

KIND Nextdoor
$13.10 /

+0.895 (+7.33%)

HUN Huntsman
$33.78 /

+0.08 (+0.24%)

ENFA 890 5th Avenue Partners
$9.98 /

+0.015 (+0.15%)

CTVA Corteva
$48.74 /

+1.06 (+2.22%)

BOX Box
$25.93 /

+0.2 (+0.78%)

ACM Aecom
$70.81 /

+0.15 (+0.21%)

VPCC VPC Impact Acquisition Holdings III
$9.98 /

-0.01 (-0.10%)

ROIV Roivant Sciences
$8.40 /

+0.57 (+7.28%)

PZZA Papa John's
$130.09 /

+0.07 (+0.05%)

OPAD Offerpad Solutions
$7.97 /

+0.305 (+3.98%)

ON ON Semiconductor
$58.59 /

+0.37 (+0.64%)

NLOK NortonLifeLock
$25.50 /

+0.46 (+1.84%)

KIND Nextdoor
$13.10 /

+0.895 (+7.33%)

HUN Huntsman
$33.78 /

+0.08 (+0.24%)

ENFA 890 5th Avenue Partners
$9.98 /

+0.015 (+0.15%)

ELAN Elanco
$33.03 /

+0.29 (+0.89%)

CTVA Corteva
$48.74 /

+1.06 (+2.22%)

BOX Box
$25.93 /

+0.2 (+0.78%)

AUS Austerlitz Acquisition Corporation I
$9.84 /

-0.11 (-1.11%)

ACM Aecom
$70.81 /

+0.15 (+0.21%)

OPAD Offerpad Solutions
$7.97 /

+0.305 (+3.98%)

ON ON Semiconductor
$58.59 /

+0.37 (+0.64%)

NLOK NortonLifeLock
$25.50 /

+0.46 (+1.84%)

KIND Nextdoor
$13.10 /

+0.895 (+7.33%)

IWN iShares Russell 2000 Value Index
$174.91 /

-0.315 (-0.18%)

IWM iShares Trust Russell 2000 Index Fund
$239.46 /

+0.21 (+0.09%)

CYXT Cyxtera Technologies
$9.56 /

-0.235 (-2.40%)

CTVA Corteva
$48.74 /

+1.06 (+2.22%)

BOX Box
$25.93 /

+0.2 (+0.78%)

AUS Austerlitz Acquisition Corporation I
$9.84 /

-0.11 (-1.11%)

IWN iShares Russell 2000 Value Index
$174.91 /

-0.315 (-0.18%)

IWM iShares Trust Russell 2000 Index Fund
$239.46 /

+0.21 (+0.09%)

Recommendations
Mednax price target lowered to $31 from $37 at BMO Capital » 06:59
11/01/21
11/01
06:59
11/01/21
06:59
MD

Mednax

$27.24 /

-0.525 (-1.89%)

BMO Capital analyst Matt…

BMO Capital analyst Matt Borsch lowered the firm's price target on Mednax to $31 from $37 and keeps a Market Perform rating on the shares after its Q3 results. Volumes were the key driver for the strong performance, as total births at hospitals where Mednax provides NICU services were up 2.8% and NICU days were up 5.6%, the analyst tells investors in a research note. Borsch further cites Mednax management stating that business "more than recovered" from negative pandemic impacts, but his reduced price target reflects a recalibrated valuation model across provider names.

ShowHide Related Items >><<
MD Mednax
$27.24 /

-0.525 (-1.89%)

MD Mednax
$27.24 /

-0.525 (-1.89%)

10/13/21 Truist
Mednax price target lowered to $31 from $37 at Truist
09/27/21 SVB Leerink
SVB Leerink starts Mednax at Market Perform with $29 price target
09/27/21 SVB Leerink
Mednax initiated with a Market Perform at SVB Leerink
08/09/21 Truist
Mednax price target raised to $37 from $32 at Truist
MD Mednax
$27.24 /

-0.525 (-1.89%)

Earnings
Mednax reports Q3 non-GAAP EPS 46c, consensus 42c » 06:02
10/28/21
10/28
06:02
10/28/21
06:02
MD

Mednax

$27.61 /

+0.5 (+1.84%)

Reports Q3 revenue $493M,…

Reports Q3 revenue $493M, consensus $480.05M. "We are pleased with our Q3 results, the strategic steps we have been taking, and the strength of our balance sheet," said CEO Mark Ordan. "Our financial performance accompanied many positive steps in the organization, the combination of which we believe positions us very well to face challenges and to seize opportunities. Our recent investment in Brave Care, which brings us a suite of innovative technology and operating systems, should enable us to accelerate our activities in pediatric primary and urgent care. All of what we are doing is part of our drive to lead in the continuum of women's and children's care."

ShowHide Related Items >><<
MD Mednax
$27.61 /

+0.5 (+1.84%)

MD Mednax
$27.61 /

+0.5 (+1.84%)

10/13/21 Truist
Mednax price target lowered to $31 from $37 at Truist
09/27/21 SVB Leerink
SVB Leerink starts Mednax at Market Perform with $29 price target
09/27/21 SVB Leerink
Mednax initiated with a Market Perform at SVB Leerink
08/09/21 Truist
Mednax price target raised to $37 from $32 at Truist
MD Mednax
$27.61 /

+0.5 (+1.84%)

Over a month ago
Recommendations
Mednax price target lowered to $31 from $37 at Truist » 09:24
10/13/21
10/13
09:24
10/13/21
09:24
MD

Mednax

$26.58 /

-0.07 (-0.26%)

Truist analyst David…

Truist analyst David MacDonald lowered the firm's price target on Mednax to $31 from $37 and keeps a Hold rating on the shares as part of a broader research note on on the Healthcare Services sector. The analyst remains "broadly bullish" on the group with some "attractive areas of opportunity", but he also warns that the ongoing labor pressures could last into 2022 while the potential impact of sequestration also adds some risk.

ShowHide Related Items >><<
MD Mednax
$26.58 /

-0.07 (-0.26%)

MD Mednax
$26.58 /

-0.07 (-0.26%)

09/27/21 SVB Leerink
SVB Leerink starts Mednax at Market Perform with $29 price target
09/27/21 SVB Leerink
Mednax initiated with a Market Perform at SVB Leerink
08/09/21 Truist
Mednax price target raised to $37 from $32 at Truist
06/22/21 Stifel
Mednax resumed with a Hold at Stifel
MD Mednax
$26.58 /

-0.07 (-0.26%)

Conference/Events
SVB Leerink health/managed care analyst holds analyst/industry conference call » 09:31
09/28/21
09/28
09:31
09/28/21
09:31
ACHC

Acadia Healthcare

$65.60 /

+0.4 (+0.61%)

, AGL

Agilon Health

$27.00 /

-1.1 (-3.91%)

, AHCO

AdaptHealth

$23.74 /

+0.73 (+3.17%)

, AMED

Amedisys

$156.15 /

+1.01 (+0.65%)

, ANTM

Anthem

$388.69 /

+7.275 (+1.91%)

, CI

Cigna

$206.64 /

+2.665 (+1.31%)

, HCA

HCA Healthcare

$255.62 /

-0.7 (-0.27%)

, HUM

Humana

$400.86 /

+1.99 (+0.50%)

, LHCG

LHC Group

$162.32 /

+2.21 (+1.38%)

, MD

Mednax

$28.77 /

-0.01 (-0.03%)

, ONEM

1Life Healthcare

$19.54 /

-1.92 (-8.95%)

, OSH

Oak Street Health

$47.16 /

+0.205 (+0.44%)

, PRVA

Privia Health

$25.78 /

+0.01 (+0.04%)

, THC

Tenet Healthcare

$69.59 /

-1.84 (-2.58%)

, UNH

UnitedHealth

$405.44 /

-1.71 (-0.42%)

Healthcare & Managed…

Healthcare & Managed Care Facilities Analyst Mayo discusses the initiation of coverage of the Industry and the following companies, ACHC AGL AHCO AMED ANTM CI HCA HUM LHCG MD ONEM OSH PRVA THC UNH, on an Analyst/Industry conference call to be held on September 28 at 11 am.

ShowHide Related Items >><<
UNH UnitedHealth
$405.44 /

-1.71 (-0.42%)

THC Tenet Healthcare
$69.59 /

-1.84 (-2.58%)

PRVA Privia Health
$25.78 /

+0.01 (+0.04%)

OSH Oak Street Health
$47.16 /

+0.205 (+0.44%)

ONEM 1Life Healthcare
$19.54 /

-1.92 (-8.95%)

MD Mednax
$28.77 /

-0.01 (-0.03%)

LHCG LHC Group
$162.32 /

+2.21 (+1.38%)

HUM Humana
$400.86 /

+1.99 (+0.50%)

HCA HCA Healthcare
$255.62 /

-0.7 (-0.27%)

CI Cigna
$206.64 /

+2.665 (+1.31%)

ANTM Anthem
$388.69 /

+7.275 (+1.91%)

AMED Amedisys
$156.15 /

+1.01 (+0.65%)

AHCO AdaptHealth
$23.74 /

+0.73 (+3.17%)

ACHC Acadia Healthcare
$65.60 /

+0.4 (+0.61%)

ACHC Acadia Healthcare
$65.60 /

+0.4 (+0.61%)

09/27/21 SVB Leerink
Acadia Healthcare initiated with an Outperform at SVB Leerink
09/27/21 SVB Leerink
Acadia Healthcare initiated with an Outperform at SVB Leerink
09/23/21 UBS
Acadia Healthcare initiated with Buy, $81 target at UBS
09/23/21 UBS
Acadia Healthcare initiated with a Buy at UBS
AGL Agilon Health
$27.00 /

-1.1 (-3.91%)

09/27/21 SVB Leerink
Agilon Health initiated with an Outperform at SVB Leerink
09/27/21 SVB Leerink
Agilon Health initiated with an Outperform at SVB Leerink
09/09/21 Cowen
Agilon Health initiated with an Outperform at Cowen
06/03/21 Wells Fargo
Agilon Health price target raised to $44 from $38 at Wells Fargo
AHCO AdaptHealth
$23.74 /

+0.73 (+3.17%)

09/27/21 SVB Leerink
AdaptHealth initiated with an Outperform at SVB Leerink
09/27/21 SVB Leerink
AdaptHealth initiated with an Outperform at SVB Leerink
07/14/21 Baird
AdaptHealth upgraded to Outperform on increasing investor confidence at Baird
07/14/21 Baird
AdaptHealth upgraded to Outperform from Neutral at Baird
AMED Amedisys
$156.15 /

+1.01 (+0.65%)

09/27/21 SVB Leerink
Amedisys initiated with a Market Perform at SVB Leerink
09/27/21 SVB Leerink
Amedisys initiated with a Market Perform at SVB Leerink
09/23/21 UBS
Amedisys initiated with a Sell at UBS
09/23/21 UBS
Amedisys initiated with a Sell at UBS
ANTM Anthem
$388.69 /

+7.275 (+1.91%)

09/27/21 SVB Leerink
Anthem initiated with a Market Perform at SVB Leerink
09/27/21 SVB Leerink
Anthem initiated with a Market Perform at SVB Leerink
09/09/21 Cowen
Anthem can gain profitable market share, says Cowen
09/09/21 Cowen
Anthem initiated with an Outperform at Cowen
CI Cigna
$206.64 /

+2.665 (+1.31%)

09/27/21
Fly Intel: Top five analyst initiations
09/27/21 SVB Leerink
Cigna initiated with a Market Perform at SVB Leerink
09/27/21 SVB Leerink
Cigna initiated with a Market Perform at SVB Leerink
09/10/21
Fly Intel: Top five analyst downgrades
HCA HCA Healthcare
$255.62 /

-0.7 (-0.27%)

09/27/21 SVB Leerink
SVB Leerink starts 'underappreciated' HCA Healthcare at Outperform at
09/27/21 SVB Leerink
HCA Healthcare initiated with an Outperform at SVB Leerink
09/23/21 UBS
HCA Healthcare initiated with Buy, $312 target at UBS
09/23/21 UBS
HCA Healthcare initiated with a Buy at UBS
HUM Humana
$400.86 /

+1.99 (+0.50%)

09/27/21 SVB Leerink
SVB Leerink 'looking through the noise,' starts Humana at Outperform
09/27/21 SVB Leerink
Humana initiated with an Outperform at SVB Leerink
09/24/21 Piper Sandler
1Life Healthcare price target lowered to $37 from $55.50 at Piper Sandler
09/09/21 Cowen
Humana initiated with an Outperform at Cowen
LHCG LHC Group
$162.32 /

+2.21 (+1.38%)

09/27/21 SVB Leerink
SVB Leerink starts LHC Group at Market Perform on near-term concerns
09/27/21 SVB Leerink
LHC Group initiated with a Market Perform at SVB Leerink
09/23/21 UBS
LHC Group initiated with a Neutral at UBS
09/23/21 UBS
LHC Group initiated with a Neutral at UBS
MD Mednax
$28.77 /

-0.01 (-0.03%)

09/27/21 SVB Leerink
SVB Leerink starts Mednax at Market Perform with $29 price target
09/27/21 SVB Leerink
Mednax initiated with a Market Perform at SVB Leerink
08/09/21 Truist
Mednax price target raised to $37 from $32 at Truist
06/22/21 Stifel
Mednax resumed with a Hold at Stifel
ONEM 1Life Healthcare
$19.54 /

-1.92 (-8.95%)

09/27/21 SVB Leerink
SVB Leerink initiates 1Life Healthcare with a Market Perform, $22 target
09/27/21 SVB Leerink
1Life Healthcare initiated with a Market Perform at SVB Leerink
08/12/21 Barclays
1Life Healthcare initiated with an Overweight at Barclays
OSH Oak Street Health
$47.16 /

+0.205 (+0.44%)

09/27/21 SVB Leerink
SVB Leerink initiates Oak Street Health with a Market Perform, $51 target
09/27/21 SVB Leerink
Oak Street Health initiated with a Market Perform at SVB Leerink
09/09/21 Cowen
Oak Street Health initiated with an Outperform at Cowen
09/08/21
Fly Intel: Top five analyst initiations
PRVA Privia Health
$25.78 /

+0.01 (+0.04%)

09/27/21 SVB Leerink
SVB Leerink initiates Privia Health with an Outperform, $35 target
09/27/21 SVB Leerink
Privia Health initiated with an Outperform at SVB Leerink
09/09/21 Cowen
Privia Health initiated with a Market Perform at Cowen
08/10/21 Credit Suisse
Oak Street-driven dip provides opportunity in Cano, Privia, says Credit Suisse
THC Tenet Healthcare
$69.59 /

-1.84 (-2.58%)

09/27/21 SVB Leerink
SVB Leerink initiates Tenet Healthcare with a Market Perform, $80 target
09/27/21 SVB Leerink
Tenet Healthcare initiated with a Market Perform at SVB Leerink
09/23/21 UBS
Tenet Healthcare initiated with a Neutral at UBS
09/23/21 UBS
Tenet Healthcare initiated with a Neutral at UBS
UNH UnitedHealth
$405.44 /

-1.71 (-0.42%)

09/27/21 SVB Leerink
UnitedHealth initiated with an Outperform at SVB Leerink
09/09/21 Cowen
UnitedHealth initiated with an Outperform at Cowen
09/08/21 Mizuho
Selloff in managed care sector overdone, says Mizuho
UNH UnitedHealth
$405.44 /

-1.71 (-0.42%)

THC Tenet Healthcare
$69.59 /

-1.84 (-2.58%)

PRVA Privia Health
$25.78 /

+0.01 (+0.04%)

OSH Oak Street Health
$47.16 /

+0.205 (+0.44%)

ONEM 1Life Healthcare
$19.54 /

-1.92 (-8.95%)

MD Mednax
$28.77 /

-0.01 (-0.03%)

LHCG LHC Group
$162.32 /

+2.21 (+1.38%)

HUM Humana
$400.86 /

+1.99 (+0.50%)

HCA HCA Healthcare
$255.62 /

-0.7 (-0.27%)

CI Cigna
$206.64 /

+2.665 (+1.31%)

ANTM Anthem
$388.69 /

+7.275 (+1.91%)

AMED Amedisys
$156.15 /

+1.01 (+0.65%)

AHCO AdaptHealth
$23.74 /

+0.73 (+3.17%)

AGL Agilon Health
$27.00 /

-1.1 (-3.91%)

ACHC Acadia Healthcare
$65.60 /

+0.4 (+0.61%)

  • 10
    Sep
  • 27
    May
  • 29
    Apr
  • 15
    Apr
  • 11
    Feb
  • 06
    Jan
  • 15
    Dec
  • 03
    Dec
  • 23
    Nov
UNH UnitedHealth
$405.44 /

-1.71 (-0.42%)

ONEM 1Life Healthcare
$19.54 /

-1.92 (-8.95%)

HUM Humana
$400.86 /

+1.99 (+0.50%)

HCA HCA Healthcare
$255.62 /

-0.7 (-0.27%)

CI Cigna
$206.64 /

+2.665 (+1.31%)

ANTM Anthem
$388.69 /

+7.275 (+1.91%)

AMED Amedisys
$156.15 /

+1.01 (+0.65%)

UNH UnitedHealth
$405.44 /

-1.71 (-0.42%)

THC Tenet Healthcare
$69.59 /

-1.84 (-2.58%)

PRVA Privia Health
$25.78 /

+0.01 (+0.04%)

OSH Oak Street Health
$47.16 /

+0.205 (+0.44%)

ONEM 1Life Healthcare
$19.54 /

-1.92 (-8.95%)

HUM Humana
$400.86 /

+1.99 (+0.50%)

HCA HCA Healthcare
$255.62 /

-0.7 (-0.27%)

CI Cigna
$206.64 /

+2.665 (+1.31%)

ANTM Anthem
$388.69 /

+7.275 (+1.91%)

AHCO AdaptHealth
$23.74 /

+0.73 (+3.17%)

AGL Agilon Health
$27.00 /

-1.1 (-3.91%)

UNH UnitedHealth
$405.44 /

-1.71 (-0.42%)

PRVA Privia Health
$25.78 /

+0.01 (+0.04%)

HCA HCA Healthcare
$255.62 /

-0.7 (-0.27%)

AGL Agilon Health
$27.00 /

-1.1 (-3.91%)

Initiation
SVB Leerink starts Mednax at Market Perform with $29 price target » 08:43
09/27/21
09/27
08:43
09/27/21
08:43
MD

Mednax

$28.81 /

-0.075 (-0.26%)

As previously reported,…

As previously reported, SVB Leerink analyst Whit Mayo initiated coverage of Mednax with a Market Perform rating and $29 price target. While he estimates Q3 revenues are tracking 5% above consensus and sees "little risk" to 2021 estimates, Mayo argues that trends in 2021 are actually deteriorating versus 2019 and he sees end-markets showing "few signs of improvement," setting up 2022 for "downside risk of mean reversion."

ShowHide Related Items >><<
MD Mednax
$28.81 /

-0.075 (-0.26%)

MD Mednax
$28.81 /

-0.075 (-0.26%)

09/27/21 SVB Leerink
Mednax initiated with a Market Perform at SVB Leerink
08/09/21 Truist
Mednax price target raised to $37 from $32 at Truist
06/22/21 Stifel
Mednax resumed with a Hold at Stifel
05/11/21 BMO Capital
Mednax price target raised to $35 from $27 at BMO Capital
MD Mednax
$28.81 /

-0.075 (-0.26%)

Initiation
Mednax initiated with a Market Perform at SVB Leerink » 06:04
09/27/21
09/27
06:04
09/27/21
06:04
MD

Mednax

$28.81 /

-0.075 (-0.26%)

SVB Leerink analyst Whit…

SVB Leerink analyst Whit Mayo initiated coverage of Mednax with a Market Perform rating and $29 price target.

ShowHide Related Items >><<
MD Mednax
$28.81 /

-0.075 (-0.26%)

MD Mednax
$28.81 /

-0.075 (-0.26%)

08/09/21 Truist
Mednax price target raised to $37 from $32 at Truist
06/22/21 Stifel
Mednax resumed with a Hold at Stifel
05/11/21 BMO Capital
Mednax price target raised to $35 from $27 at BMO Capital
05/10/21 Deutsche Bank
Mednax price target raised to $24 from $17.50 at Deutsche Bank
MD Mednax
$28.81 /

-0.075 (-0.26%)

Over a quarter ago
Recommendations
Mednax price target raised to $37 from $32 at Truist » 09:23
08/09/21
08/09
09:23
08/09/21
09:23
MD

Mednax

$33.17 /

+2.85 (+9.40%)

Truist analyst David…

Truist analyst David MacDonald raised the firm's price target on Mednax to $37 from $32 but keeps a Hold rating on the shares. The analyst cites the company's better than expected Q2 results as volume trends "accelerated quicker than anticipated" and favorable payer mix continued for a second straight quarter. MacDonald believes that Mednax is positioned for "solid organic growth" as new business bookings are already approaching FY20 levels, though at current levels, he views the risk-reward on the stock as balanced.

ShowHide Related Items >><<
MD Mednax
$33.17 /

+2.85 (+9.40%)

MD Mednax
$33.17 /

+2.85 (+9.40%)

06/22/21 Stifel
Mednax resumed with a Hold at Stifel
05/11/21 BMO Capital
Mednax price target raised to $35 from $27 at BMO Capital
05/10/21 Deutsche Bank
Mednax price target raised to $24 from $17.50 at Deutsche Bank
05/10/21 Mizuho
Mednax price target raised to $30 from $20 at Mizuho
MD Mednax
$33.17 /

+2.85 (+9.40%)

MD Mednax
$33.17 /

+2.85 (+9.40%)

Earnings
Mednax reports Q2 adjusted EPS 41c, consensus 32c » 06:04
08/06/21
08/06
06:04
08/06/21
06:04
MD

Mednax

$30.36 /

+0.67 (+2.26%)

Reports Q2 revenue $473M,…

Reports Q2 revenue $473M, consensus $448.94M.

ShowHide Related Items >><<
MD Mednax
$30.36 /

+0.67 (+2.26%)

MD Mednax
$30.36 /

+0.67 (+2.26%)

06/22/21 Stifel
Mednax resumed with a Hold at Stifel
05/11/21 BMO Capital
Mednax price target raised to $35 from $27 at BMO Capital
05/10/21 Deutsche Bank
Mednax price target raised to $24 from $17.50 at Deutsche Bank
05/10/21 Mizuho
Mednax price target raised to $30 from $20 at Mizuho
MD Mednax
$30.36 /

+0.67 (+2.26%)

MD Mednax
$30.36 /

+0.67 (+2.26%)

Hot Stocks
Mednax says CVS Aetna voluntarily dismissed 2018 litigation » 16:18
07/14/21
07/14
16:18
07/14/21
16:18
CVS

CVS Health

$82.38 /

+0.72 (+0.88%)

, MD

Mednax

$28.09 /

-0.96 (-3.30%)

Mednax (MD) announced…

Mednax (MD) announced that CVS Aetna (CVS) has voluntarily dismissed its litigation against the company. On July 14, CVS Aetna filed with the Court its voluntary dismissal of the case, putting an end to the litigation it initiated in 2018. "We are pleased that CVS Aetna has voluntarily dismissed the lawsuit that it filed against us in 2018, putting this matter fully in the past," said Mark S. Ordan, Chief Executive Officer of Mednax. "Our core mission is to do what's absolutely best for our patients: mothers and children at their most vulnerable times. CVS Aetna's website speaks the same language about care, so we hope this can be a start of building a positive relationship for the sake of our patients."

ShowHide Related Items >><<
MD Mednax
$28.09 /

-0.96 (-3.30%)

CVS CVS Health
$82.38 /

+0.72 (+0.88%)

CVS CVS Health
$82.38 /

+0.72 (+0.88%)

07/08/21 Credit Suisse
Amazon Care continues with 'see what sticks' strategy, says Credit Suisse
07/02/21 Mizuho
CVS Health came out on top in PBM checks, says Mizuho
06/22/21 Deutsche Bank
CVS Health price target lowered to $95 from $99 at Deutsche Bank
05/27/21 Mizuho
CVS, Walgreens selloff on Amazon report overdone, says Mizuho
MD Mednax
$28.09 /

-0.96 (-3.30%)

06/22/21 Stifel
Mednax resumed with a Hold at Stifel
05/11/21 BMO Capital
Mednax price target raised to $35 from $27 at BMO Capital
05/10/21 Deutsche Bank
Mednax price target raised to $24 from $17.50 at Deutsche Bank
05/10/21 Mizuho
Mednax price target raised to $30 from $20 at Mizuho
MD Mednax
$28.09 /

-0.96 (-3.30%)

CVS CVS Health
$82.38 /

+0.72 (+0.88%)

CVS CVS Health
$82.38 /

+0.72 (+0.88%)

MD Mednax
$28.09 /

-0.96 (-3.30%)

CVS CVS Health
$82.38 /

+0.72 (+0.88%)

CVS CVS Health
$82.38 /

+0.72 (+0.88%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.